The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics

Diabetologia. 2015 Jul;58(7):1436-42. doi: 10.1007/s00125-015-3587-7. Epub 2015 Apr 17.


Aims/hypothesis: The risk of developing diabetes is greater for women with previous gestational diabetes mellitus (GDM). In the general population, plasma lipidomic analysis can identify individuals at risk of developing type 2 diabetes. The aim of this study was to determine whether circulating lipid levels 12 weeks following a GDM pregnancy were associated with an increased risk of developing type 2 diabetes.

Methods: Plasma lipid profiles containing >300 lipids were measured in 104 normal glucose-tolerant women 12 weeks following an index GDM pregnancy using electrospray-ionisation tandem mass spectrometry. Women were assessed for 10 years for development of overt type 2 diabetes.

Results: Among the 104 women with previous GDM, 21 (20%) developed diabetes during the median follow-up period of 8.5 years. Three lipid species, the cholesteryl ester species CE 20:4, the alkenylphosphatidylethanolamine species PE(P-36:2) and the phosphatidylserine species PS 38:4, were independently and positively associated with the development of type 2 diabetes. In a clinical model of prediction of type 2 diabetes that included age, BMI, and levels of pregnancy fasting glucose, postnatal fasting glucose, triacylglycerol and total cholesterol, the addition of these three lipid species resulted in an improvement in the net reclassification index of 22.3%.

Conclusions/interpretation: The lipid species CE 20:4, PE(P-36:2) and PS 38:4 were significant risk factors for the development of type 2 diabetes in women with a previous history of GDM. This report is the first to use plasma lipidomic analysis to identify individual lipids as potential biomarkers for the prediction of type 2 diabetes in women with a history of GDM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Glucose / analysis
  • Body Mass Index
  • Cholesterol / blood
  • Cholesterol Esters / blood
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes, Gestational / diagnosis*
  • Female
  • Follow-Up Studies
  • Glucose Tolerance Test
  • Humans
  • Lipids / blood*
  • Phosphatidylethanolamines / blood
  • Phosphatidylserines / blood
  • Pregnancy
  • Risk Assessment
  • Tandem Mass Spectrometry
  • Triglycerides / blood
  • Young Adult


  • Blood Glucose
  • Cholesterol Esters
  • Lipids
  • Phosphatidylethanolamines
  • Phosphatidylserines
  • Triglycerides
  • Cholesterol